OTC Markets OTCPK - Delayed Quote • USD NaturalShrimp Incorporated (SHMP) Follow Compare 0.0010 +0.0004 +(66.67%) At close: January 16 at 3:00:00 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations NaturalShrimp, Inc. Continues Production Despite Setbacks DALLAS, TX, Sept. 17, 2024 (GLOBE NEWSWIRE) -- NaturalShrimp, Inc. (OTCQB: SHMP) (the “Company” or “NSI”), a Biotechnology Aquaculture Company that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), today announced that, despite recent litigation, it has entered into discussions with Streeterville Capital, LLC (“Streeterville”) to resolve current issues, including the litigation, and to continue growing and expanding the producti Natural Shrimp E-Commerce Update Natural Shrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused commercially operational RAS (Recirculating Aquaculture System), announces that it has launched its online ordering home delivery website at www.naturalshrimpharvest-select.com, including a new dedicated fulfilment center with an upgraded ordering process. Natural Shrimp, Inc. Announces New Markets for Sale of Shrimp Natural Shrimp, Incorporated. (OTCQB: SHMP) (the "Company" or "NSI"), a Biotechnology Aquaculture Company that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), today announced that, as a result of significantly increased production at its Webster City facility, the Company is in the process of identifying, contacting and securing new commercial outlets for the sale of the Company's sushi grade shrimp. Natural Shrimp, Inc. Completes Successful Trial in Japan Natural Shrimp, Inc. (OTCQB: SHMP) (the "Company" or "NSI"), a Biotechnology Aquaculture Company that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), today announced it has completed at the end of February 2024 a successful 6-month trial in Japan with the Company's patented Electrocoagulation (EC) and Hydrogas™ technologies (the "Equipment"). Natural Shrimp Announces Filing of Application to List on Cboe US Natural Shrimp Incorporated (OTCQB: SHMP), a Biotechnology Aquaculture Company (the "Company") that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), is pleased to announce that the Company has filed an initial application to list its securities on the Chicago Board of Options Exchange (Cboe US) BZX exchange (the "Exchange"). In addition, the Company has extended its engagement with its investment banking partner to underwrite a NaturalShrimp, Inc. Files International Patent Applications NaturalShrimp Incorporated (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused commercially operational RAS (Recirculating Aquaculture System), is pleased to announce the successful filing of patents in Japan, Thailand, and Australia. These filings mark a significant step in our commitment to advancing sustainable aquaculture practices and ensuring the future of global seafood production. Performance Overview Trailing total returns as of 1/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return SHMP S&P 500 YTD -66.67% +0.51% 1-Year -91.67% +24.11% 3-Year -99.74% +27.33%